300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
Social Network
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Nigeria
Isle of Man
Pakistan
Romania
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Cameroon
Oman
Australia
Colombia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Startup Investors in Israel (June 2026)

The most active venture capital funds and angel investors investing in Israel Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Israel Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Pontifax
VC Fund
10 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$110M
OurCrowd
VC Fund
10 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $612k–$70M
Btomorrow Ventures
VC Fund
4 United States, United Kingdom, India Series A, Seed, Series B Health Care, Wellness, Food and Beverage
HBL Hadasit Bio Holdings
VC Fund
4 Israel Series A, Series B Biotechnology, Medical, Health Care
Triventures
VC Fund
4 United States, Israel, Ireland Series A, Series B Health Care, Medical Device, Medical $3.7M–$28M
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
Terra Venture Partners
VC Fund
3 Israel, United States Seed, Series A, Series B Software, Machine Learning, Artificial Intelligence $1M–$30M
Trendlines Group
VC Fund
3 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $650k–$15M
aMoon Fund
VC Fund
3 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Docor International Management
VC Fund
3 Israel, United States Series C, Series A Health Care, Biotechnology, 3D Technology $13M–$22M
Champel Capital
VC Fund
2 Israel, United States, Switzerland Series B, Series A, Seed Artificial Intelligence, Health Care, Software
SCP Vitalife Partners
VC Fund
2 Israel, United States Series C, Series D Health Care, Medical, Medical Device $1.2M–$43M
Tal Ventures
VC Fund
2 Israel, United States, Cyprus Seed, Series A, Series B Software, Artificial Intelligence, SaaS $3M–$120M
S2G Ventures
VC Fund
2 United States, Canada, Israel Series A, Series B Food and Beverage, Agriculture, Biotechnology
ALIVE Israel HealthTech Fund
VC Fund
2 Israel, United States Series A, Series B Health Care, Medical, Biotechnology
Neo Ventures
VC Fund
2 Israel, United Kingdom, Estonia Seed, Series A Software, Artificial Intelligence, Aerospace
Indaco Venture Partners
VC Fund
2 Italy, United States, United Kingdom Series A, Series B Biotechnology, Health Care, Medical
Rimonci Capital
VC Fund
2 Israel Series A, Series B, Series C Health Care, Medical Device, Medical
Flerie Invest
VC Fund
2 Sweden, Israel, Iceland Series A, Series B Biotechnology, Health Care, Medical
Technion - Israel Institute of Technology
VC Fund
2 Israel, United States Seed, Series B Medical, Health Care, Drones $2.2M–$20M
MTIP AG
VC Fund
2 United States, United Kingdom, Spain Series A, Series B, Series C Health Care, Artificial Intelligence, Medical $1.5M–$80M
Shimon Eckhouse
Angel
2 Israel Seed Medical, Biotechnology, Fitness
Smith & Nephew
VC Fund
2 Israel, United States, United Kingdom Series B, Series C Medical Device, Medical, Health Care
Hanaco Venture Capital
VC Fund
2 Israel, United States, United Kingdom Series A, Seed, Series B Software, FinTech, SaaS $3M–$56M
Robin Hood Ventures
VC Fund
2 United States, Israel Seed, Series A Software, Health Care, Biotechnology $100k–$11M
Accelmed
VC Fund
2 Israel, United States Series D, Series A Health Care, Medical Device, Medical $695k–$96M
Group 11
VC Fund
2 United States, Israel Series A, Series B, Seed FinTech, Software, Financial Services $1.5M–$100M
Integra Holdings
VC Fund
2 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Yozma Group
VC Fund
2 Israel, United States, Australia Series B, Seed Health Care, Medical, Software $2.5M–$59M
Clal Biotechnology Industries
VC Fund
2 Israel, United States Series A, Series B Health Care, Biotechnology, Medical $4M–$55M
Mithril Capital Management
VC Fund
2 United States, United Kingdom, Israel Series C, Series B, Series D Software, Health Care, Information Technology $10M–$300M
Lightspeed Venture Partners
VC Fund
2 United States, India, Israel Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $2.2M–$125M
Vertex Ventures Israel
VC Fund
2 Israel, United States, Canada Series A, Series B, Series C Software, Information Technology, Artificial Intelligence $3.3M–$100M
Qure Ventures
VC Fund
2 United States, Israel Series A, Series B, Series C Health Care, Medical Device, Medical $11M–$20M
Mangrove Capital Partners
VC Fund
2 United States, United Kingdom, Israel Series A, Seed, Series B Software, E-Commerce, Information Technology $675k–$25M
Entrée Capital
VC Fund
2 United States, Israel, United Kingdom Seed, Series A, Series B Software, FinTech, Financial Services $1.4M–$55M
Firstime Venture Capital
VC Fund
2 Israel, United States, United Kingdom Series A, Seed, Series B Software, Artificial Intelligence, Health Care $500k–$21M
OTV
VC Fund
2 United States, Israel, Ghana Series A, Series B, Seed Health Care, Medical, Medical Device $5M–$50M
Israel Innovation Authority
VC Fund
2 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Biotechnology, Medical Device $130k–$6M
ZORA Ventures
VC Fund
2 Israel, United States, United Kingdom Seed, Series A, Convertible Note Health Care, Biotechnology, Internet $1M–$7M
SeedIL Ventures
VC Fund
2 Israel, United States, United Kingdom Seed, Series A, Pre-Seed Software, Artificial Intelligence, Big Data $1.7M–$21M
Arkin Holdings
VC Fund
2 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$95M
Grove Ventures
VC Fund
2 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.5M–$74M
Connecticut Innovations
VC Fund
2 United States, Israel, Canada Seed, Series A Health Care, Biotechnology, Software $200k–$25M
CE Ventures (CEIIF)
VC Fund
2 Israel, United States, India Series B, Series A, Series C Software, Analytics, Big Data $4M–$40M
Marius Nacht
Angel
2 Israel, United States, Germany Series A, Seed Artificial Intelligence, Health Care, Machine Learning $3M–$120M
Zohar Gilon
Angel
2 Israel, United States Seed, Series A, Series B Software, Internet, Health Care $1.5M–$15M
OrbiMed
VC Fund
2 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
HealthpointCapital
VC Fund
2 Israel, United States Series B, Series C Medical, Biotechnology, Manufacturing $5M–$15M
Eclipse
VC Fund
2 United States, Canada, Israel Series A, Series B, Seed Software, Robotics, Artificial Intelligence $2M–$105M
Access all 467 investors in Israel Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 10 investments in Israel Medical startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 111
  • Round size: Series A $6.3M–$110M; Series B $20M–$100M; Series C $12M–$104M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 10 investments in Israel Medical startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 264
  • Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
  • PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
  • BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Show all investments...

Btomorrow Ventures
VC Fund · London, England, United Kingdom · 4 investments in Israel Medical startups, 6 in the past 12 months

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 44
  • Lead/follow: no public data

Portfolio highlights

  • Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
  • Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
  • PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 4 investments in Israel Medical startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 4 investments in Israel Medical startups

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 60
  • Round size: Series A $3.7M–$20M; Series B $6M–$28M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • TailorMed — Moving Mountains for Patients
Show all investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Israel Medical startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

Terra Venture Partners
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Israel Medical startups

We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies

Show more...

Investment focus

  • Industry: Software, Machine Learning, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2013

Portfolio highlights

  • ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
  • Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
  • Intuition Robotics — The AI care companion robot for older adults
Show all investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 3 investments in Israel Medical startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 69
  • Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 3 investments in Israel Medical startups, 7 in the past 12 months

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 76
  • Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, 3D Technology
  • Stage:Series C, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series C $13M–$22M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Champel Capital
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Israel Medical startups

As a young and dynamic company with a spirit of entrepreneurship, we look first and foremost at the vision leading the entrepreneur. We believe that we should be investing in people, before everything else. We want to be investing in companies led by entrepreneurs who are capable of envisioning and growing great companies with products and/or services meeting real market needs in large and growing markets.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Software
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Lynxight — Lynxight creates computer vision applications for underwater operations. The company offers a platform with a set of applications utilized across multiple industries: pools, aquaculture, energy, maritime security and infrastructure, among others. Powered by proprietary AI technology, Lynxight enables superior capabilities to manage safety risksand improve operational performance: object detection, measurement and recognition, behavioral analysis, action classification, trajectory optimization and anomaly modeling to predict and forewarn of unplanned situations.Lynxight is hardware agnostic and can be applied in any environment using imaging from above/below water.
  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • Intelligent Traffic Control — Intelligent Traffic Control is an adaptive AI-based traffic light real-time management system. It uses advance Supervised and Unsupervised Machine Learning algorithms to make a real-time analysis of the intersection situation, recognize the traffic pattern and tendencies, and changing the green light allocation per lane accordingly, assuringminimum waiting time at the intersection by maximizing the intersection capability.ITC mathematically proved that there are many traffic jams that the system can prevent. It accumulates the algorithm based on a complex mathematical equation and set of algorithms.
Show all investments...

SCP Vitalife Partners
VC Fund · Wayne, Pennsylvania, United States · 2 investments in Israel Medical startups

SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series C, Series D
  • Geography: Israel, United States

Investor stats

  • Total investments: 12
  • Round size: Series C $10M–$25M; Series D $1.2M–$43M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS).  The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
  • Ivenix — Bring the power of guided workflows, adaptive fluid delivery, and complete secondary delivery with an Ivenix IV Infusion System. Explore now.
  • Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Show all investments...

Tal Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States, Cyprus

Investor stats

  • Total investments: 55
  • Round size: Seed $3M–$12M; Series A $5M–$25M; Series B $35M–$120M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Octup — Elevate your e-commerce business with our comprehensive E-commerce Operations Platform. Streamline processes, boost efficiency, and drive sales growth!
  • Fibery — Create a custom workspace for all roles in your company. Connected databases, customizable views, powerful reports, automations, integrations, and more. You name it, we have it.
  • BeWith.io (Superc AI) — Connect residents and foster engagement with a centralized community calendar that brings all city events into one easy-to-access platform
Show all investments...

S2G Ventures
VC Fund · Chicago, Illinois, United States · 2 investments in Israel Medical startups, 12 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 159
  • Lead/follow: no public data

Portfolio highlights

  • Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
  • Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
  • Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Show all investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 2 investments in Israel Medical startups

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Aerospace
  • Stage:Seed, Series A
  • Geography: Israel, United Kingdom, Estonia

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible.
  • Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
  • GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
  • Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Show all investments...

Rimonci Capital
VC Fund · 2 investments in Israel Medical startups

A dedicated to China-Israel cross border investment.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
  • EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
  • BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
Show all investments...

Flerie Invest
VC Fund · 2 investments in Israel Medical startups

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Sweden, Israel, Iceland

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
  • Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Show all investments...

Technion - Israel Institute of Technology
VC Fund · Haifa, Hefa, Israel · 2 investments in Israel Medical startups

“Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.

Show more...

Investment focus

  • Industry: Medical, Health Care, Drones
  • Stage:Seed, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $2.2M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
  • Lydus Medical — Automated micro anastomosis for ultra-small vessels LEARN MORE Microvascular anastomosis is the predominant challenge in cardiovascular, transplant, and reconstructive microsurgery. This high dexterity skill has a long learning curve and has long been performed by hand using a needle and suture, resulting in suboptimal ischemic time, post-procedure complications and
  • Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
MTIP AG
VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in Israel Medical startups

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 24
  • Round size: Series A $1.5M–$33M; Series B $10M–$30M; Series C $27M–$80M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
  • Koa Health — Make mental health manageable, treatable, and approachable for every industry and every individual with clinical-first care designed by experts. From evidence-based self-care and prevention through clinical treatment and therapy, Koa Health supports workforce wellbeing across the continuum.
  • Intelligencia AI — Intelligencia is an enterprise SaaS company that applies Machine Learning to assess and mitigate the risk in clinical development strategy/design.
Show all investments...

Shimon Eckhouse
Angel · 2 investments in Israel Medical startups

Shimon Eckhouse

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Fitness
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Show all investments...

Smith & Nephew
VC Fund · London, England, United Kingdom · 2 investments in Israel Medical startups

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
  • Michelson Diagnostics — Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.
Show all investments...

Hanaco Venture Capital
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Hanaco Venture Capital is a technology company with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.

Show more...

Investment focus

  • Industry: Software, FinTech, SaaS
  • Stage:Series A, Seed, Series B
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 95
  • Round size: Seed $3M–$11M; Series A $6M–$33M; Series B $20M–$56M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Curve — Curve is a banking platform that consolidates cards and accounts into one smart card and app.It allows customers to supercharge their legacy banks to the 21st century without leaving their bank or topping-up. Curve offers a host of benefits to its customers; it makes cards fee-free when spending abroad, get instant notifications andcategorization of spend, earn an instant 1% cashback at the likes of Amazon, Uber, Netflix and Sainsbury’s and Time Travel enables customers to swap spend to a different card in the app for up to two weeks after the purchase was made. Curve also offers Curve Customer Protection, a policy that covers all credit and debit card payments made via the Curve card up to £100,000, giving cardholders an extra layer of protection for disputes with merchants and any unauthorised use of their Curve card. IDC Ventures backs Curve with Fuel Venture Capital, Vulcan Capital, OneMain Financial, and Novum Capital backs Curve.Shachar Bialick, Anna Mostyn Williams, and Tom Foster-Carter established the company in London, England in 2015.
  • SpotitEarly — SpotitEarly offers a new approach for cancer pre-screening, with a single at-home test for multiple cancer types, all based on one breath sample.
  • Sepio — Sepio Zero Trust Hardware Security enhances network security by seeing, assessing, and mitigating risk across all known and shadow IT assets.
Show all investments...

Robin Hood Ventures
VC Fund · Philadelphia, Pennsylvania, United States · 2 investments in Israel Medical startups

Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 130
  • Round size: Seed $210k–$3M; Series A $100k–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Epoxy.ai — We make sports viewing and gaming easy and fun for everyone
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Lia — LIA Diagnostics is redesigning pregnancy tests to addresses the challenges surrounding privacy, usability and sustainability in current pregnancy tests.
Show all investments...

Accelmed
VC Fund · Aventura, Florida, United States · 2 investments in Israel Medical startups

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 37
  • Round size: Series A $695k–$24M; Series D $13M–$96M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • NeuroPace — The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
  • Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
  • GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Show all investments...

Group 11
VC Fund · Beverly Hills, California, United States · 2 investments in Israel Medical startups

Group 11 invests in visionary entrepreneurs who are utilizing the unstoppable momentum of AI and FinTech to redraw the landscape of their respective industries. With a goal of creating change across generations and building long term value through technology, Group 11 has emerged as a coveted partner to veteran entrepreneurs at the forefront oftheir fields. Since its inception in 2012, the firm has deployed over $600 million across six funds in some of the world’s most prominent and disruptive technology companies, including: Tipalti, Navan, Next Insurance, HomeLight, Sunbit, Masterschool, Healthee, Dream, and BridgeWise.

Show more...

Investment focus

  • Industry: FinTech, Software, Financial Services
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel

Investor stats

  • Total investments: 76
  • Round size: Seed $1.5M–$22M; Series A $6M–$34M; Series B $11M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • venn — Venn creates a new way of urban neighboring by managing homes, creating shared spaces, supporting hyperlocal business initiatives and services, programs events, and facilitating community engagement – all on a neighborhood-wide level. Operating by the motto, “If they build it, they will stay,” venn’s platform encourages urbanites to become activecreators and participants in the development of their community and enables developing neighborhoods to become as vibrant and desirable as the downtown core. Founded in 2016 by people raised in the Big City and in cooperative communities, venn is a new movement of neighboring that impacts tens of thousands of people in three cities (Tel Aviv, Brooklyn, and Berlin) with +75 employees
  • Healthee — Insurights is an AI-powered digital platform that allows employees to utilize their health benefits and coverage. It provides employees on-the-spot answers to their health coverage and benefits questions, helps them find lower-cost providers, and lets them know about relevant preventive care benefits to ensure they are healthier.
  • Dream Security — Dream Security provides critical infrastructure defensive cyber solutions.
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 2 investments in Israel Medical startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Yozma Group
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Yozma earned worldwide recognition as the founder of Israel's VC industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Series B, Seed
  • Geography: Israel, United States, Australia

Investor stats

  • Total investments: 24
  • Round size: Seed $4M–$4.5M; Series B $2.5M–$59M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • BiSiChem — Invent targeted small molecule drugs that are either first-in-class or second-generation
  • Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
  • Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $4M–$55M; Series B $15M–$33M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
  • Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mithril Capital Management
VC Fund · San Francisco, California, United States · 2 investments in Israel Medical startups

Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series C, Series B, Series D
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 67
  • Round size: Series B $10M–$150M; Series C $15M–$142M; Series D $15M–$300M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $850M in 2017

Portfolio highlights

  • Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
  • GreyOrange — Learn about GreyOrange 2026 from GreyOrange, where AI-driven warehouse and retail store solutions reduce costs, increase accuracy and power omnichannel success.
  • Helion Energy — Enabling a future with unlimited clean energy
Show all investments...

Lightspeed Venture Partners
VC Fund · Menlo Park, California, United States · 2 investments in Israel Medical startups

Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, Israel

Investor stats

  • Total investments: 1497
  • Round size: Seed $2.2M–$30M; Series A $6.5M–$90M; Series B $13M–$125M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $2.4B in 2022

Portfolio highlights

  • k-ID — At k-ID, we specialize in integrating safety and privacy by design compliance solutions for digital platforms, focusing on creating a safer, more responsible online environment for children and teenagers.
  • CuspAI — CuspAI is a revolutionary AI startup that is developing a platform for next-generation materials to address global sustainability and renewable energy concerns. CuspAI uses cutting-edge generative AI, deep learning, and molecular simulation to accelerate the material design process. Their platform works similarly to a search engine for materials,allowing users to request certain properties for new materials on demand.
  • Fiddler Labs — Monitor, observe, analyze, and explain your machine learning models in production with Fiddler AI. Maximize ML model performance with our Model Performance Management Platform that simply plugs in.
Show all investments...

Vertex Ventures Israel
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

We partner early with global-minded entrepreneurs seeking to disrupt large markets

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Canada

Investor stats

  • Total investments: 180
  • Round size: Series A $3.3M–$28M; Series B $4.7M–$35M; Series C $5.6M–$100M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2018

Portfolio highlights

  • Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
  • Seal Security — Streamline your open source vulnerability remediation without introducing the risk of breaking changes. Say goodbye to alert fatigue and start patching with Seal Security.
  • Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Show all investments...

Qure Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel

Investor stats

  • Total investments: 8
  • Round size: Series A $11M–$20M; Series B $20M–$20M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
  • Sweetch — Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabeticpopulation, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.
  • Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Show all investments...

Mangrove Capital Partners
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Israel Medical startups

Mangrove Capital Partners is a contrarian investment firm helping innovative entrepreneurs start and grow.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 146
  • Round size: Seed $675k–$9.5M; Series A $2.5M–$12M; Series B $8M–$25M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $234M in 2017

Portfolio highlights

  • WalkMe — Using technology should be the way we overcome challenges, not the challenge itself.
  • Sifflet — You make important business decision based on your data. Sifflet ensures the data is reliable, traceable and easy to navigate.
  • Lightico — AI Intelligent Document Processing, IDP, ID Verification, KYC and Compliant Customer Journeys for Banks, Auto Finance, Telecoms.
Show all investments...

Entrée Capital
VC Fund · London, England, United Kingdom · 2 investments in Israel Medical startups

We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 256
  • Round size: Seed $1.4M–$13M; Series A $4M–$25M; Series B $14M–$55M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
  • Toka — Toka develops cutting-edge and lawful digital forensics, intelligence and force protection capabilities to empower government agencies strengthen homeland security.
  • Imagindairy — It's dairy, done differently. Our animal-free dairy products are lactose-free, growth hormone-free and cholesterol-free.
Show all investments...

Firstime Venture Capital
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 81
  • Round size: Seed $600k–$6M; Series A $500k–$10M; Series B $12M–$21M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2017

Portfolio highlights

  • Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
  • Securithings — Bringing IT Standards to the IoT Space.
  • STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
Show all investments...

OTV
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, Ghana

Investor stats

  • Total investments: 21
  • Round size: Seed $5M–$8M; Series A $6M–$12M; Series B $16M–$50M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $170M in 2020

Portfolio highlights

  • Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
  • Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
  • Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Israel Medical startups, 16 in the past 12 months

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 152
  • Round size: Seed $590k–$6M; Grant $130k–$4M; Pre-Seed $150k–$2.5M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Q-Factor
  • Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

ZORA Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Internet
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $1M–$7M; Series A $4M–$6M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SeedIL Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

We invest in the best Israeli founders. Boutique seed-stage VC with personalized support and international connections.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Big Data
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 31
  • Round size: Seed $1.7M–$7M; Series A $2.2M–$21M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BlinqIO — Autonomously develop and maintain flawless automation code, combining Generative AI's power with human oversight for scalable testing solutions
  • Quack — Get your team the power to resolve user issues right away.
  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $270M in 2021

Portfolio highlights

  • Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
  • Eleos Health — Eleos Health provides AI-powered, highly compliant documentation automation to ease the operational burden on behavioral healthcare providers.
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Show all investments...

Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups, 8 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 2 investments in Israel Medical startups

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 251
  • Round size: Seed $200k–$5.3M; Series A $2.4M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $50M in 2023

Portfolio highlights

  • NorthPage — NorthPage provides a cloud-based digital marketing optimization platform that enables frictionless performance benchmarking, competitive analysis, and best-practice guidance for enterprise marketing organizations. Its solutions enable optimization of Websites, e-commerce sites, mobile marketing, social media, search engine marketing, contentmarketing, and e-retail programs. The company serves retail, financial services, consumer product, pharmaceutical, and technology companies. NorthPage Inc. was founded in 2007 and is based in Southbury, Connecticut.
  • IntelliBoard — The IntelliBoard Learning Analytics Platform helps you retain students, increase their engagement, and manage compliance.
  • Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
Show all investments...

CE Ventures (CEIIF)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Israel Medical startups

CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.

Show more...

Investment focus

  • Industry: Software, Analytics, Big Data
  • Stage:Series B, Series A, Series C
  • Geography: Israel, United States, India

Investor stats

  • Total investments: 34
  • Round size: Series A $4M–$7M; Series B $4M–$30M; Series C $10M–$40M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
  • Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Show all investments...

Marius Nacht
Angel · Tel Aviv-yafo, Tel Aviv, Israel · 2 investments in Israel Medical startups

Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Machine Learning
  • Stage:Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $3M–$120M; Series A $5M–$23M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
  • WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
  • Ultima Genomics — Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health.
Show all investments...

Zohar Gilon
Angel · 2 investments in Israel Medical startups

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

Show more...

Investment focus

  • Industry: Software, Internet, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 33
  • Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
  • Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
  • Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 2 investments in Israel Medical startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 589
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Show all investments...

HealthpointCapital
VC Fund · New York, New York, United States · 2 investments in Israel Medical startups

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 7
  • Round size: Series B $5M–$13M; Series C $12M–$15M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Show all investments...

Eclipse
VC Fund · Palo Alto, California, United States · 2 investments in Israel Medical startups

Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.

Show more...

Investment focus

  • Industry: Software, Robotics, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 199
  • Round size: Seed $2M–$30M; Series A $7.5M–$55M; Series B $15M–$105M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $510M in 2023

Portfolio highlights

  • Syng — Syng is an audio company transforming the human relationship with sound. their hardware and software platform gives creators and listeners the power to engage with, explore, and share sound in transformative new ways.
  • Oxide Computer Company — Servers as they should be. Hardware, with the software baked in, for running infrastructure at scale. Shipping early 2022.
  • Senser — Senser is the eBPF-powered AIOps platform that teams use to rapidly identify and resolve service issues in distributed environments.
Show all investments...

Medical Investor funding in Israel at a glance

Stats across 377 deals from 467 investors.

467
investors
in Israel Medical startups
377
deals
in Israel Medical startups
$7M
median round
in Israel Medical startups
36%
lead investors
lead at least one round
18%
Seed
most common funding stage
91/9
VC / Angel
share of investor count

Access all 467 investors in Israel Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 467 investors investing in Israel Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists